Porous Silicon and Polymer Nanocomposites for Delivery of Peptide Nucleic Acids as Anti-MicroRNA Therapies-Reference-Cited by-同舟云学术

Porous Silicon and Polymer Nanocomposites for Delivery of Peptide Nucleic Acids as Anti-MicroRNA Therapies

Published:2016-07-06 Issue:36 Volume:28 Page:7984-7992
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Beavers Kelsey R.¹,Werfel Thomas A.²,Shen Tianwei²,Kavanaugh Taylor E.²,Kilchrist Kameron V.²,Mares Jeremy W.³,Fain Joshua S.³,Wiese Carrie B.⁴,Vickers Kasey C.⁵,Weiss Sharon M.³,Duvall Craig L.²

Affiliation:

1. Interdisciplinary Graduate Program in Materials Science; Vanderbilt University; Nashville TN 37235 USA

2. Department of Biomedical Engineering; Vanderbilt University; Nashville TN 37235 USA

3. Department of Electrical Engineering and Computer Science; Vanderbilt University; Nashville TN 37235 USA

4. Department of Molecular Physiology & Biophysics; Vanderbilt University; Nashville TN 37235 USA

5. Department of Medicine/Division of Cardiovascular Medicine; Vanderbilt University; Nashville TN 37235 USA

Funder

National Institutes of Health

National Sleep Foundation

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Reference34 articles.

1. Peptide Nucleic Acids: On the Road to New Gene Therapeutic Drugs

2. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides

3. In Situ Synthesis of Peptide Nucleic Acids in Porous Silicon for Drug Delivery and Biosensing

4. PNA-based microRNA inhibitors elicit anti-inflammatory effects in microglia cells

5. miR-122 targeting with LNA/2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA–peptide conjugates

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Porous silicon and silica carriers for delivery of peptide therapeutics;Drug Delivery and Translational Research;2024-05-31

2. Porous silicon and silica carriers for delivery of peptide therapeutics;2024-01-04

3. Inhibition of miR-574-5p as Innovative First-in-Class Disease-Modifying Treatment Approach for Osteoarthritis;2024

4. Harnessing the Materials Chemistry of Mesoporous Silicon Nanoparticles to Prepare “Armor-Clad” Enzymes;Chemistry of Materials;2023-11-24

5. Development of microRNA-based therapeutics for central nervous system diseases;European Journal of Pharmacology;2023-10